Table 1.
Baseline demographic and clinical characteristics
| Co-careldopa (n=308) | Placebo (n=285) | |||
|---|---|---|---|---|
| Age, years | 67·5 (13·6) | 69·6 (12·7) | ||
| Sex | ||||
| Men | 187 (61%) | 177 (62%) | ||
| Women | 121 (39%) | 108 (38%) | ||
| Ethnicity | ||||
| White | 289 (94%) | 270 (95%) | ||
| Asian | 9 (3%) | 8 (2%) | ||
| Black | 3 (1%) | 5 (2%) | ||
| Chinese | 2 (1%) | 1 (<1%) | ||
| Mixed | 2 (1%) | 1 (<1%) | ||
| Other | 3 (1%) | 0 | ||
| Type of stroke | ||||
| Infarction* | 270 (88%) | 238 (84%) | ||
| Total Anterior Circulation | 98 (36%) | 63 (27%) | ||
| Lacunar | 58 (22%) | 58 (24%) | ||
| Partial Anterior Circulation | 87 (32%) | 91 (38%) | ||
| Posterior Circulation | 27 (10%) | 25 (11%) | ||
| Missing | .. | 1 (<1%) | ||
| Primary haemorrhage | 38 (12%) | 47 (17%) | ||
| Thrombolysis received | 62 (23%) | 59 (25%) | ||
Data are mean (SD) or n (%).
*
Oxfordshire Community Stroke Project classification.